Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates.
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
21
10
2019
accepted:
06
03
2020
entrez:
20
5
2020
pubmed:
20
5
2020
medline:
9
4
2022
Statut:
epublish
Résumé
Dopaminergic neuronal cell death, associated with intracellular α-synuclein (α-syn)-rich protein aggregates [termed "Lewy bodies" (LBs)], is a well-established characteristic of Parkinson's disease (PD). Much evidence, accumulated from multiple experimental models, has suggested that α-syn plays a role in PD pathogenesis, not only as a trigger of pathology but also as a mediator of disease progression through pathological spreading. Here, we have used a machine learning-based approach to identify unique signatures of neurodegeneration in monkeys induced by distinct α-syn pathogenic structures derived from patients with PD. Unexpectedly, our results show that, in nonhuman primates, a small amount of singular α-syn aggregates is as toxic as larger amyloid fibrils present in the LBs, thus reinforcing the need for preclinical research in this species. Furthermore, our results provide evidence supporting the true multifactorial nature of PD, as multiple causes can induce a similar outcome regarding dopaminergic neurodegeneration.
Identifiants
pubmed: 32426502
doi: 10.1126/sciadv.aaz9165
pii: aaz9165
pmc: PMC7220339
doi:
Substances chimiques
Amyloid
0
alpha-Synuclein
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eaaz9165Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Références
Nucleic Acids Res. 2010 Sep;38(17):e169
pubmed: 20660011
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
Nat Commun. 2019 Mar 7;10(1):973
pubmed: 30846695
Nat Neurosci. 2020 Jan;23(1):21-31
pubmed: 31792467
Behaviour. 1974;49(3):227-67
pubmed: 4597405
J Biol Chem. 2019 Jul 5;294(27):10392-10406
pubmed: 31142553
Trends Neurosci. 1989 Oct;12(10):366-75
pubmed: 2479133
Brain. 2019 Nov 1;142(11):3565-3579
pubmed: 31580415
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4194-9
pubmed: 21325059
Elife. 2018 Jul 03;7:
pubmed: 29969391
Sci Transl Med. 2010 Apr 21;2(28):28ra28
pubmed: 20410529
Acta Neuropathol. 2017 Dec;134(6):819-838
pubmed: 28803412
Nature. 2016 Oct 05;538(7623):20-23
pubmed: 27708329
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Acta Neuropathol Commun. 2015 Jul 25;3:46
pubmed: 26205255
Brain. 1991 Aug;114 ( Pt 4):1953-75
pubmed: 1832073
J Neuropathol Exp Neurol. 2004 Dec;63(12):1225-35
pubmed: 15624759
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113
pubmed: 28104909
J Neurosci. 2010 Sep 15;30(37):12535-44
pubmed: 20844148
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
Eur J Pharmacol. 2015 Jul 15;759:118-26
pubmed: 25841877
Ann Neurol. 2014 Mar;75(3):351-62
pubmed: 24243558
Neurobiol Dis. 2015 Jul;79:81-99
pubmed: 25937088
Nat Med. 2015 Dec;21(12):1406-15
pubmed: 26646497
Mov Disord. 2016 Feb;31(2):161-8
pubmed: 26347034
Mov Disord. 2012 Oct;27(12):1478-83
pubmed: 23008164
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Exp Neurol. 2004 Sep;189(1):1-4
pubmed: 15296829
Protein Sci. 2004 Dec;13(12):3314-21
pubmed: 15537750
PLoS One. 2013 Jul 04;8(7):e67711
pubmed: 23861787
Trends Neurosci. 2019 Jan;42(1):4-13
pubmed: 30342839
Front Behav Neurosci. 2014 Feb 19;8:47
pubmed: 24600363
Nat Struct Mol Biol. 2016 May;23(5):409-15
pubmed: 27018801
Nat Commun. 2013;4:2575
pubmed: 24108358
Nat Med. 2017 Feb 7;23(2):1-13
pubmed: 28170377
Nat Med. 2008 May;14(5):501-3
pubmed: 18391963
Neurosci Lett. 2009 Apr 3;453(2):77-80
pubmed: 19356597
J Biol Chem. 2012 Sep 28;287(40):33691-705
pubmed: 22843695
Acta Neuropathol. 2003 Jul;106(1):83-8
pubmed: 12687392
Prog Neurobiol. 2017 Aug;155:171-193
pubmed: 26209472
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S210-2
pubmed: 22166438
Sci Rep. 2017 Jun 20;7(1):3902
pubmed: 28634347
Brain Res. 2009 Aug 25;1286:208-14
pubmed: 19559009
Nat Struct Mol Biol. 2019 Nov;26(11):1044-1052
pubmed: 31695184
Nature. 2015 Sep 24;525(7570):486-90
pubmed: 26352473
Nat Commun. 2019 Dec 4;10(1):5535
pubmed: 31797870
J Neurosci. 2001 Sep 1;21(17):6853-61
pubmed: 11517273
Nat Med. 2008 May;14(5):504-6
pubmed: 18391962
PLoS One. 2013 Apr 29;8(4):e62141
pubmed: 23658620
Hum Mol Genet. 2014 Jun 1;23(11):2802-15
pubmed: 24399444
Cell Res. 2018 Sep;28(9):897-903
pubmed: 30065316
Nat Med. 2008 May;14(5):507-9
pubmed: 18391961
Hum Mol Genet. 2017 Jul 15;26(14):2603-2615
pubmed: 28520872